Biotricity is a modern medical technology company focused on delivering innovative, remote biometric monitoring solutions to the medical and consumer markets, including diagnostic and post diagnostic solutions for chronic conditions and lifestyle improvement. To learn more, visit www.biotricity.com.
Quote | Biotricity Inc. (OTCMKTS:BTCY)
Last: | $2.91 |
---|---|
Change Percent: | -18.72% |
Open: | $2.8 |
Close: | $2.91 |
High: | $3.05 |
Low: | $2.3 |
Volume: | 1,573,491 |
Last Trade Date Time: | 08/26/2021 04:40:20 am |
News | Biotricity Inc. (OTCMKTS:BTCY)
Democratizing cardiac health with convenient, rapid, and reliable results REDWOOD CITY, CA / ACCESSWIRE / June 28, 2024 / Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consume...
2024-06-27 18:40:27 ET Biotricity, Inc. (BTCY) Q4 2024 Earnings Conference Call June 27, 2024, 04:30 PM ET Company Participants Waqaas Al-Siddiq - Founder and CEO John Ayanoglou - CFO Conference Call Participants Michael Donovan - H.C. Wainwright Pr...
Message Board Posts | Biotricity Inc. (OTCMKTS:BTCY)
Subject | By | Source | When |
---|---|---|---|
$BTCY MomentumIts trading | stoneroad | investorshub | 07/04/2023 10:53:30 PM |
Price now | Bcl40004$ | investorshub | 07/03/2023 2:32:44 PM |
short squeeze all day | Bullz | investorshub | 07/01/2023 1:30:28 PM |
What do you make of this? | HeilHiden | investorshub | 07/01/2023 12:29:21 PM |
$BTCY should we be shorting? | cheynew | investorshub | 07/01/2023 11:49:36 AM |
News, Short Squeeze, Breakout and More Instantly...
Democratizing cardiac health with convenient, rapid, and reliable results REDWOOD CITY, CA / ACCESSWIRE / June 28, 2024 / Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consume...
FY24 revenue up 25.2% YOY FY24 margins improved 1280 basis points to 69.3%, from 56.5% in the prior year; Q4-FY24 margins improved to 71.5%; margin expansion forecasted to continue FY24 operating expenses lower by 17.6% YOY Negative EBITDA reduced by $7.2 million - an improvement o...
REDWOOD CITY, CA / ACCESSWIRE / June 12, 2024 / Biotricity Inc. (NASDAQ:BTCY), a forerunning Technology-as-a-Service (TaaS) company committed to disrupting the healthcare industry with cutting-edge medical and consumer diagnostic solutions, today announces the highly anticipated launch of its di...